[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address Please contact the publisher to request reinstatement.
[Skip to Content Landing]
August 22, 1994

Marked Improvement of Diabetic Diarrhea With the Somatostatin Analogue Octreotide

Author Affiliations

From the Department of Internal Medicine (II), School of Medicine, Kanazawa University, Ishikawa (Japan) (Drs Nakabayashi, Fujii, and Takeda), and Department of Internal Medicine, Ishikawa Prefectural Central Hospital (Drs Miwa and Seta).

Arch Intern Med. 1994;154(16):1863-1867. doi:10.1001/archinte.1994.00420160103014

Somatostatin and its long-acting analogue octreotide have been used in various diarrheal disorders, including neoplastic and nonneoplastic diseases of the gastrointestinal tract. In two insulin-dependent diabetic patients with autonomic neuropathy and chronic steatorrheic diarrhea refractory to conventional medications, subcutaneous administration of octreotide markedly improved the volume and frequency of stools in both patients. This change was accompanied by a clear improvement in their rapid gastrointestinal tract transit times. The treatment also greatly improved their orthostatic hypotension. No adverse effects of octreotide were observed after treatment for 7 months in one patient and 2 months in the other.

(Arch Intern Med. 1994;154:1863-1867)